🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 037326105
- Market Cap
- Small Cap
- IPO
- 3/25/2022 · $15.00/share
Business: AN2 Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on the discovery and development of novel small-molecule therapeutics derived from our boron chemistry platform.
Company Contact
- CEO
- Eric Easom
- CFO
- Lucy Day
- Headquarters
- 1800 El Camino Real, Suite D, Menlo Park, CA 94027
- Phone
- 650-331-9090
- Investor Relations
- Anne Bowdidge · 650-331-9090 · info@an2therapeutics.com